Suppressed activities of cathepsins and metalloproteinases in the chronic model of puromycin aminonucleoside nephrosis

Kidney and Blood Pressure Research

Volumn 22, Issue 3, 1999, Pages 121-127

  Huang, Shaoming ^c   Schaefer, Roland M ^c   Reisch, Stefan ^c   Paczek, Leszek ^c   Schaefer, Liliana ^c   Teschner, Markus ^c   Sebekova, Katarina ^a   Heidland, August ^b  

^a INST OF PREV AND CLINICAL MEDICINE   (Slovakia)

^b UNIVERSITY OF WÜRZBURG   (Germany)

^c NONE

Author keywords

Cathepsins; Collagenase; Gelatinase; Glomerulosclerosis; Tubulointerstitial fibrosis

Indexed keywords

CATHEPSIN B; CATHEPSIN H; CATHEPSIN L; COLLAGENASE; GELATINASE; METALLOPROTEINASE; PUROMYCIN AMINONUCLEOSIDE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; GLOMERULUS; KIDNEY FIBROSIS; KIDNEY PROXIMAL TUBULE; MALE; MESANGIUM; NEPHROSIS; NONHUMAN; PRIORITY JOURNAL; PROTEINURIA; RAT;

EID: 0032785210     PISSN: 14204096     EISSN: None     Source Type: Journal    
DOI: 10.1159/000025917     Document Type: Article

References (38)

1. Fine L: The biology of renal hypertrophy. Kidney Int 1986;29:619-634.
2. Baricos WH: Decreased proteolysis of the glomerular extracellular matrix as a pathogenetic mechanism in progressive renal disease. J Nephrol 1994;7:322-328.
3. Teschner M, Schaefer RM, Svarnas A, Heidland U, Heidland A: Decreased proteinase activity in isolated glomeruli of streptozotocin diabetic rats. Am J Nephrol 1989;9:464-469.
4. Olbricht CJ, Geissinger B: Renal hypertrophy in streptozotocin diabetic rats: Role of proteolytic enzymes. Kidney Int 1992;41:966-972.
5. Shechter P, Boner G, Rabkin R: Tubular cell protein degradation in early diabetic renal hypertrophy. J Am Soc Nephrol 1994;4:1582-1587.
6. Paczek L, Teschner M, Schaefer RM, Kovar J, Romen W, Heidland A: Intraglomerular proteinase activity in Adriamycin-induced nephropathy. Nephron 1992;60:81-86.
7. Schaefer L, Han X, Gretz N, Häfner C, Meier K, Matzkies F, Schaefer RM: Tubular gelatinase A (MMP-2) and its tissue inhibitors in polycystic kidney disease in the Han:SPRD rat. Kidney Int 1996;49:75-81.
8. Tomooka S, Border WA, Marshall BC, Noble NA: Glomerular matrix accumulation is linked to inhibition of the plasmin protease system. Kidney Int 1992;42:1462-1469.
9. Heidland A, Sebekova K, Paczek L, Teschner M, Dämmrich J, Gaciong Z: Renal fibrosis: Role of impaired proteolysis and potential therapeutic strategies. Kidney Int 1997;52 (suppl 62):32-35.
10. Olbricht CJ, Cannon JK, Garg LC, Tisher CC: Activities of cathepsin B and L in isolated nephron segments from proteinuric and non-proteinuric rats. Am J Physiol 1986;250: F1055-F1062.
11. Sagar S, Gibbons E, Valderrama E, Singhal PC: Glomerular metalloproteinase activity modulates the development of focal segmental glomerulonephrosis. Clin Nephrol 1995;44: 356-361.
12. Jones CL, Buch S, Post M, McCulloch L, Liu E, Eddy AA: Renal extracellular matrix accumulation in acute puromycin aminonucleoside nephrosis in rats. Am J Pathol 1992;141:1381-1396.
13. Schaefer L, Lorenz T, Dämmrich J, Heidland A, Schaefer RM: Role of proteinases in renal hypertrophy and matrix accumulation. Nephrol Dial Transplant 1995;10:801-807.
14. Barrett AJ: Fluorimetric assays for cathepsin B and cathepsin H with methylcoumarylamide substrates. Biochem J 1980;187:909-912.
15. Tschesche H, Macartney HW: Collagenase; in Bergmeyer HU, Bergmeyer J, Grassl M (eds): Methods of Enzymatic Analysis. Weinheim, Verlag Chemie, 1984, pp 239-248.
16. Tschesche H, Macartney HW, Fedrowitz J: Gelatinase: in Bergmeyer HU, Bergmeyer J, Grassl M (eds): Methods of Enzymatic Analysis. Weinheim, Verlag Chemie, 1984, pp 155-159.
17. Lowry OH, Rosebrough NJ, Farr AL, Randall RJ: Protein measurement with the Folin phenol reagent. J Biol Chem 1951;193:265-275.
18. Maniatis T, Fritsch E, Sambrook J: Molecular Cloning: A Laboratory Manual. New York, Cold Spring Harbor Laboratory, 1982, pp 458-468.
19. Baricos WH, Shah SV: Proteolytic enzymes as mediators of glomerular injury. Kidney Int 1991;40:161-173.
20. Lovett DH, Sterzel RB, Kashgarian M, Ryan JL: Neutral proteinase activities produced in vitro by cells of the glomerular mesangium. Kidney Int 1983;23:342-349.
21. Davies M, Martin J, Thomas GJ, Lovett DH: Proteinases and glomerular matrix turnover. Kidney Int 1992;41:671-678.
22. Martin J, Davies M, Thomas G, Lovett DH: Human mesangial cells secrete a GBM-degrading neutral proteinase and a specific inhibitor. Kidney Int 1989;36:790-801.
23. Baricos WH, Cortez SL, El-Dahr SS, Schnaper HW: ECM degradation by cultured human mesangial cells is mediated by a PA/plasmin/MMP-2 cascade. Kidney Int 1995;47:1039-1047.
24. Boike G, Lah T, Sloane BF, Rozhin J, Honn K, Guirguis R, Stracke ML, Liotta LA, Schiffmann E: A possible role for cysteine proteinase and its inhibitors in mortality of malignant melanoma and other tumor cells. Melanoma Res 1992;1:333-340.
25. Abbate M, Zoja C, Corna D, Capitanio M, Bertani T, Remuzzi G: In progressive nephropathies, overload of tubular cells with filtered proteins translates glomerular permeability dysfunction into cellular signals of interstitial inflammation. J Am Soc Nephrol 1998;9:1213-1224.
26. Remuzzi G, Bertani T: Is glomerulosclerosis a consequence of altered glomerular permeability to macromolecules? Kidney Int 1990;38: 384-394.
27. Kurtz I: Role of ammonia in the induction of renal hypertrophy. Am J Kidney Dis 1991; 17:650-653.
28. Huang S, Teschner M, Schaeter RM, Heidland A: Effect of metabolic acidosis on tubular proteinase activity. Nephron 1994;66:344-347.
29. 4Cl: Role of depressed activities of cathepsins due to elevated lysosomal pH. Kidney Int 1998;53:1706-1712.
30. Schoolwerth AC, Sandler RS, Hoffmann PM, Klahr S: Effects of nephron reduction and dietary protein content on renal ammoniagenesis in the rat. Kidney Int 1975;7:397-404.
31. Chobanian MC, Julin CM: Angiotensin II stimulates ammoniagenesis in canine renal proximal tubule segments. Am J Physiol 1991;260:F19-F26.
32. Border WA, Ruoslahti E: Transforming growth factor-beta in disease: The dark side of tissue repair. J Clin Invest 1992;90:1-7.
33. Edwards DR, Murphy G, Reynolds JJ, Whitham SE, Docherty AJ, Angel P, Heath JK: TGF-β modulates the expression of collagenase and metalloproteinase inhibitor. EMBO J 1987;6:1899-1904.
34. Laiho M, Saksela O, Keski-Oja J: TGF-β induction of type-1 plasminogen activator inhibitor. J Biol Chem 1987;262:17467-17474.
35. Ling H, Vamvakas S, Busch G, Daemmrich J, Schramm L, Lang F, Heidland A: Suppressing role of transforming growth factor-β1 on cathepsin activity in cultured kidney tubule cells. Am J Physiol 1995;269:F911-F917.
36. Ding G, Pesek-Diamond I, Diamond JR: Cholesterol, macrophages, and gene expression of TGF-β1 and fibronectin during nephrosis. Am J Physiol 1993;264:F577-F584.
37. Nakamura T, Ebihara I, Fukui M, Cisada S, Nagaoka I, Horikoshi S, Tomino Y, Koide H: Messenger RNA expression for growth factors in glomeruli from focal glomerulosclerosis. Clin Immunol Immunopathol 1993;66:33-42.
38. Eddy A: Protein restriction reduces transforming growth factor β and interstitial fibrosis in nephrotic syndrome. Am J Physiol 1994;266: F884-F893.